In this first edition of ERS Vision Live, which was hosted on the ERS Respiratory Channel, discussions focused on the positive outcomes of the COVID-19 pandemic - highlighting the response of key stakeholders in terms of innovation and improved communications and collaborations, which all help to deliver better outcomes for patients and support healthcare systems worldwide.

Topics

• Distribution and supply of essential medicines and medical devices
• Novel vaccine development, regulatory approval and delivery
• Rapid trials for evaluation of new therapies, vaccines, and respiratory devices in a pandemic
• Better communications/digital health and support for healthcare professionals - and between all key stakeholders

The panel

ERS President Prof. Anita Simonds and ERS Science Council Chair Prof. Christopher E. Brightling led the discussion and were joined by:

• Dr Hans Kluge - WHO Regional Director for Europe
• Manuela Buxo - Head of Europe at Sanofi Genzyme
• Sir Stephen Holgate - Clinical Professor of Immunopharmacology, University of Southampton/Co-founder of Synairgen
• Sir Menelas Pangalos, EVP & President BioPharmaceuticals R&D, AstraZeneca
• Katrin Pucknat - CEO and President, ResMed Germany